BUY, SELL, HOLD (2)

Eli Lilly Stock Surges on Billion-Dollar Acquisition, Upbeat Forecast

LLY options can be had for a pretty penny, too

Digital Content Manager
Dec 15, 2020 at 10:04 AM
facebook X logo linkedin


The shares of Eli Lilly And Co (NYSE:LLY) are up 1.9% at $160.83 at last check, after the pharmaceutical giant said it would buy Prevail Therapeutics (PRVL) for $1.04 billion, in an effort to expand its presence in the lucrative field of gene therapy. In addition, the company announced a better-than-expected 2021 financial forecast, and updated its 2020 guidance to reflect roughly $24.7 billion in revenue -- well above Wall Street's estimates.

Digging deeper, Eli Lilly stock has experienced its fair share of volatility over the past several months. The shares climbed all the way to a July 9 all-time-high of $170.75. And by November, LLY was back near $130, which roughly coincides with its year-to-date breakeven level. Nevertheless, the equity is up 22.4% in 2020, with this recent stretch of gains supported by its ascending 10-day moving average and a longer-term bullish trendline.

There's optimism abound in the options pits, where calls are king. This is per the the security's 10-day call/put volume ratio of 3.88 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits higher than 95% of readings from the past year. In simpler terms, calls are being picked up at a quicker-than-usual clip.

It's more of the same today, with calls trading at double the average intraday amount. Leading the charge this morning is the November 155 call, where buy-to-open activity is suspected.

Now could be an opportune time to take advantage of the security's next move with options. The stock's Schaeffer's Volatility Index (SVI) of 32% sits in the relatively low 24th percentile of its annual range. This means LLY currently sports attractively priced premiums.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.